Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

droperidol

droperidol
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Inapsine SOLUTION, INJECTABLE 2.5 mg/mL      
Comments:

Formulary, restricted to Emergency Department providers for treatment of refractory nausea/vomiting.

 

EKG should be obtained prior to administration if patient is known to be receiving any high-risk QTc prolonging drugs.

If the patient receives a repeat dose of droperidol, check EKG prior to administration of the repeat dose.  Maximum total dose is 2.5 mg per 24 hours.

Refer to ED Droperidol Criteria for Use for approved doses and routes of administration.

 

 

Reviewed: May 2025

 

Droperidol (INAPSINE) Update May 2025.pdf 

 

Last updated: Jul. 18, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved